Intercell with new CBO
Austrian vaccine developer Intercell AG (Vienna) has a new Chief Business Officer. At the beginning of October, Staph Leavenworth Bakali quit Intercell’s supervisory board and joined its management board with key responsibilities in Marketing and Sales, Corporate and Business Development, and Alliance Management. Bakali has been working for 20 years in the vaccine industry, and is a former CEO of Boston-based Genocea Biosciences. Prior to that he was COO at Canadian ID Biomedical and PowderJect (Oxford, UK) after stints at Chiron and SmithKline Beecham.